Levophencynonate
Alternative Names: (L)-phencynonate; (L)-phencynonate hydrochloride; L-hydrochloric acid phencynonate; L-LPC; L-phencynonate; L-phencynonate hydrochloride; Levo phencynonate hydrochloride; Levophencynonate hydrochloric; LH tabletLatest Information Update: 19 Jul 2019
At a glance
- Originator Academy of Military Medical Sciences
- Developer Sihuan Pharmaceutical Holdings Group
- Class Antiemetics; Aza compounds; Glycolates
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Vertigo
Most Recent Events
- 19 Jul 2019 Discontinued - Preregistration for Vertigo in China (PO)
- 04 Apr 2017 Preregistration for Vertigo in China (PO) before April 2017 (Sihuan Pharmaceutical pipeline, April 2017)